Back

Assembly Biosciences to present at H.C. Wainwright conference Sept. 16

Verifying
  • Assembly Biosciences will present senior management at H.C. Wainwright’s 28th Annual Global Investment Conference.
  • The presentation begins at 8:30 a.m. Eastern Time on September 16, 2026.
  • Assembly Bio develops treatments for serious viral and liver diseases, including HDV and HBV infections.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.
Assembly Biosciences to present at H.C. Wainwright conference Sept. 16 - CoinPost Terminal